Free Trial
NASDAQ:DGNX

Diginex (DGNX) Stock Price, News & Analysis

Diginex logo
$16.60 -3.83 (-18.75%)
As of 03:51 PM Eastern

About Diginex Stock (NASDAQ:DGNX)

Advanced

Key Stats

Today's Range
$15.66
$20.30
50-Day Range
$6.30
$31.39
52-Week Range
$0.45
$39.85
Volume
890,880 shs
Average Volume
1.28 million shs
Market Capitalization
$3.05 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Receive DGNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diginex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DGNX Stock News Headlines

Diginex (NASDAQ:DGNX) Trading Down 12.3% - Time to Sell?
Diginex launches diginexGHG AI-powered platform
Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
Shorting The Market Bubble With Limited Fundamental Risk
See More Headlines

DGNX Stock Analysis - Frequently Asked Questions

Diginex's stock was trading at $1.0714 on January 1st, 2025. Since then, DGNX shares have increased by 1,409.2% and is now trading at $16.17.

Diginex's stock split on the morning of Monday, September 8th 2025.The 7-1 split was announced on Monday, August 18th 2025. The newly created shares were distributed to shareholders after the market closes on Friday, September 5th 2025. An investor that had 100 shares of stock prior to the split would have 700 shares after the split.

Diginex (DGNX) raised $9 million in an initial public offering (IPO) on Wednesday, January 22nd 2025. The company issued 2,300,000 shares at a price of $4.10 per share. Dominari Securities and Revere Securities served as the underwriters for the IPO.

Shares of DGNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
10/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Technology Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:DGNX
Previous Symbol
NASDAQ:DGNX
CIK
2010499
Web
N/A
Fax
N/A
Employees
21
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
183,950,000
Free Float
N/A
Market Cap
$3.58 billion
Optionable
N/A
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:DGNX) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners